ASSETS UNDER MANAGEMENT

ADDITIONAL INVESTMENT

COMPANIES

Indiana Seed Fund I $6M (fully invested)

Indiana Seed Fund II $8.25M (fully invested)

Indiana Seed Fund III $9M

Venture Capital Funds

In 2003, BioCrossroads established the Indiana Future Fund I as a leading source of venture financing for Indiana opportunities. The Indiana Future Fund I is a $73 million fund of funds that is managed by AlpInvest Partners. Significant investments include Endocyte (Nasdaq:ECYT), Purdue’s first start-up to reach $1.5B market cap and Colucid, purchased by Eli Lilly and Company for $960M in 2018.   In December 2009, BioCrossroads established a successor fund – the $58 million INext Fund. As with the Indiana Future Fund, the INext Fund is organized as a return-driven, fund of funds that is also managed by AlpInvest Parners. In 2017, the State of Indiana established the Next Level Indiana Fund, a $250 million return-driven fund of funds managed by 50 South Capital and focused on Indiana’s innovation community.  Members of BioCrossroads executive team serve on an advisory board to 50 South Capital.

TOP 100 LIFE SCIENCES COMPANIES IN INDIANA*

*BY EMPLOYMENT